BCS1L and leukemia: It is the first time to unravel the prognostic value of KMT2A expression, but not mutation, in gastric cancer, although KMT2A mutations, including KMT2A-PTD, have been demonstrated as a potential predictor in other cancer, particularly in leukemia [29].